Decrypt the Code of Disease and Explore Healing DNA

Standard and Quality. Never Compromise

The goal

Promote genomic medicine and cross-field medical research as the goal, with cancer and infectious diseases as the main research axis, and then propose new treatment and prevention technologies and strategies; by integrating basic and clinical research, it is expected to further enhance Taiwan’s precision medicine research and The core strength of detection.

LEOPARD GENE is committed to creating a more dignified life and medical treatment for cancer patients. Therefore, it focuses on strengthening the medical quality and needs of each patient. It is related to molecular diagnosis, cancer mutation gene detection, cell therapy, and protein cancer drug development. Fields and key technologies, combined with Taipei Veterans General Hospital’s abundant experience in cancer pathology, to jointly build an international-level cancer laboratory to carry out multiple oncogene screening, testing and research and development projects to benefit cancer patient.

Lihpao Medical Laboratory

Lihpao Laboratory was established on December 31, 2019, combining genetic technology to develop precision medical laboratories that comply with ISO15189 regulations and have obtained TAF certification. It provides high-end medical laboratory services required by various medical institutions, and uses advanced molecular diagnostic technology to diagnose the correct genetic problems in time, find the correct target therapy for cancer diseases, and improve the cure rate.

Yeezen Lihpao Genomic Laboratory

Yeezen Lihpao Genomic Laboratory is located in Yeezen Hospital and has obtained the “Laboratory Developed Tests and Services; LDTS” certification from the Food and Drug Administration of the Ministry of Health and Welfare. It uses precision medicine to bring patients the best treatment opportunities, transparent genetic information can greatly improve research and development efficiency, and accurate cancer genetic testing can increase the probability of medical success. In terms of precision medical technology, it can start from R&D and testing to innovative treatments.

Lihpao (Xiamen) Medical Laboratory

Libao Xiamen Medical Laboratory, the laboratory in Xiamen of Lihpao life science Corp, officially opened on March 25, 2017.

In November of the same year, it was selected by the Xiamen Development and Reform Commission as the “Xiamen City Genetic Testing Application Demonstration Center” and obtained the “Medical Testing Laboratory” license in May 2018. Due to the outbreak of the new coronavirus, Lihpao Xiamen Medical Laboratory was obtained the qualification for new coronavirus antibody testing on August 18, 2020, and worked hard to fight the epidemic.